找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: China Food and Drug Law; Policy, Practice, an John C. Balzano Book 2024 The Editor(s) (if applicable) and The Author(s), under exclusive li

[復(fù)制鏈接]
樓主: 瘦削
21#
發(fā)表于 2025-3-25 05:36:55 | 只看該作者
Agency Jurisdiction Over Food and Drug Law, the National Medical Products Administration, which plays the primary national role in the regulation of drugs (small molecule drugs and biologics), medical devices and cosmetics, and similar attention to the divisions and affiliated food evaluation center of the State Administration for Market Regulation, which regulates finished food products.
22#
發(fā)表于 2025-3-25 09:13:21 | 只看該作者
Biosecurity and FDD Research and Development, most prominent role in this area in China are the human genetic resource (HGR) regulations. This chapter examines the development of the area of biosecurity overall, with particular attention to the HGR regulatory regime.
23#
發(fā)表于 2025-3-25 14:11:28 | 只看該作者
24#
發(fā)表于 2025-3-25 19:41:18 | 只看該作者
Cosmetics Regulation in China,ncreasingly mainstream online sales. But the regime still contains requirements and processes that are onerous, particularly as compared to other jurisdictions. This chapter explores the recent evolution and the current state of affairs.
25#
發(fā)表于 2025-3-25 21:28:16 | 只看該作者
26#
發(fā)表于 2025-3-26 00:26:03 | 只看該作者
Administrative Law Concepts and Enforcement Powers,ve agencies and through the courts. This chapter discusses the ways in which enforcement begins, the collection of different types of evidence and their different persuasive values within the system, and the appeal process.
27#
發(fā)表于 2025-3-26 05:26:12 | 只看該作者
28#
發(fā)表于 2025-3-26 10:03:04 | 只看該作者
Medical Device Regulation,sk-based regulation over the life cycle of devices, into the post-market environment. It also examines more specific methods for regulating certain types of devices, including digital health products, through specific standards and, more recently, technical guidelines.
29#
發(fā)表于 2025-3-26 13:50:19 | 只看該作者
Adverse Events with Biomedicines the National Medical Products Administration, which plays the primary national role in the regulation of drugs (small molecule drugs and biologics), medical devices and cosmetics, and similar attention to the divisions and affiliated food evaluation center of the State Administration for Market Regulation, which regulates finished food products.
30#
發(fā)表于 2025-3-26 17:29:35 | 只看該作者
Adverse Drug Events to Biomedicines most prominent role in this area in China are the human genetic resource (HGR) regulations. This chapter examines the development of the area of biosecurity overall, with particular attention to the HGR regulatory regime.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 23:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
颍上县| 六安市| 基隆市| 襄垣县| 万州区| 尉犁县| 崇仁县| 墨竹工卡县| 习水县| 山东| 汉中市| 尉犁县| 澎湖县| 寿宁县| 岳普湖县| 沙雅县| 博罗县| 沙湾县| 民县| 阿拉善左旗| 资溪县| 桑日县| 新泰市| 绥芬河市| 灵石县| 浦县| 闽侯县| 伊宁县| 平阳县| 澳门| 宣威市| 南充市| 阿拉善盟| 江安县| 泰和县| 高安市| 灵武市| 阿克陶县| 长武县| 达州市| 灵寿县|